E-LIB Suche - Ergebnisse für: Gergis, Usama

1

Chimeric Antigen Receptor T-Cell Access in Patients with Re..:

Ahmed, Nausheen ; Sun, Fang ; Teigland, Christie...
Transplantation and Cellular Therapy. 30 (2024) 7 - p. 714-725 , 2024

Link: https://doi.org/10.1016/..

2

Safety and Feasibility of Third-Party Cytotoxic T Lymphocyt..:

Grosso, Dolores ; Wagner, John L. ; O'Connor, Allyson...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

3

A prospective study of posttransplant cyclophosphamide for ..:

Jeurkar, Chetan ; Leiby, Benjamin ; Rashid, Shaik...
European Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

4

Correction to: Projected Impact of Omidubicel-onlv on Racia..:

Khera, Nandita ; Edwards, Marie Louise ; Song, Yan...
Advances in Therapy. 41 (2024) 7 - p. 3013-3013 , 2024

Link: https://doi.org/10.1007/..

5

Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens (..:

Patel, Krina K. ; Rodríguez-Otero, Paula ; Nooka, Ajay K....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S322 , 2024

Link: https://doi.org/10.1016/..

6

Projected Impact of Omidubicel-onlv on Racial/Ethnic Dispar..:

Khera, Nandita ; Edwards, Marie Louise ; Song, Yan...
Advances in Therapy. 41 (2024) 4 - p. 1637-1651 , 2024

Link: https://doi.org/10.1007/..

7

Donor-Derived Malignancy and Transplantation Morbidity: Ris..:

Williams, Lacey S. ; Williams, Kirsten M. ; Gillis, Nancy...
Transplantation and Cellular Therapy. 30 (2024) 3 - p. 255-267 , 2024

Link: https://doi.org/10.1016/..

8

Health care costs among patients with hematologic malignanc..:

Maziarz, Richard T. ; Gergis, Usama ; Edwards, Marie Louise...
Blood Advances. 8 (2024) 5 - p. 1200-1208 , 2024

Link: https://doi.org/10.1182/..

9

Outcome of Multiple Myeloma Patients Undergoing Allogeneic ..:

Yang, Yang ; Binder, Adam F ; Bi, Xia...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S378-S379 , 2024

Link: https://doi.org/10.1016/..

10

Donor Types and Outcomes of Transplantation in Myelofibrosi..:

Jain, Tania ; Estrada-Merly, Noel ; Salas, M. Queralt...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

11

Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell..:

Elgohary, Ghada ; Yang, Yang ; Gergis, Mia..
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 4 - p. e142-e151 , 2024

Link: https://doi.org/10.1016/..

12

P-008 Idecabtagene vicleucel (ide-cel) vs standard regimens..:

Einsele, Hermann ; Rodriguez-Otero, Paula ; Arnulf, Bertrand...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S37 , 2023

Link: https://doi.org/10.1016/..

13

Expert consensus on microtransplant for acute myeloid leuke..:

Ai, Huisheng ; Chao, Nelson J. ; Rizzieri, David A....
Heliyon. 9 (2023) 4 - p. e14924 , 2023

Link: https://doi.org/10.1016/..

14

Outcomes for Anti-CD19+ Chimeric Antigen Receptor T (CAR-T)..:

Battiwalla, Minoo ; Tees, Michael ; Flinn, Ian W....
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S211 , 2023

Link: https://doi.org/10.1016/..

15

Impact of second primary malignancy post–autologous transpl..:

Ragon, Brittany Knick ; Shah, Mithun Vinod ; D'Souza, Anita...
Blood Advances. 7 (2023) 12 - p. 2746-2757 , 2023

Link: https://doi.org/10.1182/..